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Abstract
Background: Atrial fibrillation (AF) is common in patients with heart failure (HF) and worsens their prognosis.
Vulnerability to changes in loading is an important factor in the development of AF and is strongly influenced
by ventricular stiffness and ventriculo-arterial interaction. The aim of this study was to investigate predictors of AF
development in patients with HF.
Methods: We studied 349 patients with stable HF. The following parameters of ventricular stiffness and ventriculo-arterial
interaction were derived from echo-Doppler measurements: left ventricular (LV) diastolic elastance (Ed), effective arterial
elastance (Ea), LV end-systolic elastance (Ees) and ventricular–vascular coupling index (VVI).
Results: AF occurred in 57 (16.3 %) patients over a median follow up of 30.3 months. Echo-Doppler–derived parameters
of ventricular stiffness and ventriculo-arterial interaction were closely associated with HF severity. Ed was independently
associated with AF after adjustment for age, hypertension, diabetes mellitus, and left atrial volume index (hazard ratio [HR]
5.49, p = 0.018). Ea and VVI were also associated with new-onset AF (HR 1.66, p = 0.027, and HR 1.06,
p = 0.001, respectively).
Conclusions: Echo-Doppler indexes of ventricular stiffness are closely associated with HF severity. LV diastolic elastance
(Ed) is the strongest predictor of new-onset AF in HF patients.
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Background
Heart failure (HF) and atrial fibrillation (AF) each affect
1–2 % of the general population and the prevalence of
both increases with age [1, 2]. AF is the most common
sustained arrhythmia and occurs in 15 to 30 % of pa-
tients with HF [3, 4]. Since AF is a marker of increased
cardiovascular mortality and morbidity in patients with
HF [5, 6], it is important to investigate the predictors of
AF occurrence in these patients. The development of AF
in HF appears to be a multifactorial process, involving
structural and neurohormonal processes and electrical
remodeling [7]. The heart’s vulnerability to changes in
loading affects the prognosis of HF and the development
of AF. As this vulnerability is affected by ventricular
stiffness and ventriculo-arterial interaction [8, 9], it is
reasonable to hypothesize that those factors are closely
associated with the development of AF. However, the
relationship has still not been determined in HF patients.
Therefore, the aim of this study was to investigate
indexes of ventricular stiffness and ventriculo-arterial
interaction as predictors for the development of AF in
patients with HF.
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Methods
Study populations
We retrospectively investigated 349 consecutive patients
(238 men; age 62 ± 15 years) with stable HF with normal
sinus rhythm who had undergone echocardiography be-
tween January 2007 and December 2008 in our institution.
Reduced left ventricular (LV) contractility was defined as
either a reduced ejection fraction (EF) (EF < 40 %) or a bor-
derline EF (40 % ≤ EF < 50 %), based on two-dimensional
echocardiography [10]. Exclusion criteria were (1) muscu-
lar dystrophy, (2) more than moderate valvular disease, (3)
previously documented AF or atrial flutter on the electro-
cardiogram (ECG) or Holter monitoring, (4) significant
lung disease and (5) a New York Heart Association func-
tional classification III or IV.
We reviewed medical history, physical examinations,
laboratory tests, medication records, chest radiographs,
12-lead ECG, and echocardiography findings in all
patients. We followed the study population for the devel-
opment of AF via a review of their medical records. New-
onset AF was defined as the first episode of paroxysmal or
persistent AF, as documented by resting ECG or 24-h
Holter monitoring, during the follow-up period. When
the patient presented symptoms such as palpitations or
dizziness, 24-h Holter monitoring was performed. Parox-
ysmal AF was defined as AF that terminated spontan-
eously within seven days, and persistent AF as continuous
AF that was sustained beyond seven days [5]. Study proto-
cols were approved by our institutional review board, and
informed consent from patients was waived due to retro-
spective nature of the study.
Conventional echocardiography
Two-dimensional, pulsed-Doppler, and tissue-Doppler
echocardiographic examinations were performed using an
appropriate ultrasound device (Sonos 7500, Philips, or
Vivid 7, GE healthcare). Standard 2-dimensional measure-
ments—LV diastolic and systolic dimension, ventricular
septum and posterior wall thicknesses, left atrial (LA)
volume, and LV outflow tract diameter—were obtained,
based on the recommendations of the American Society of
Echocardiography [6]. LVEF was calculated from minimal
(LV end-systole just before mitral valve opening) and max-
imal (LV end-diastole at the start of the QRS) LV volumes,
which were obtained using a modified Quinones method
[5]. LA volume was determined by the prolate ellipsoid
formula and was indexed to the body surface area [6]. Peak
velocities of early diastolic filling (E) and late diastolic
filling (A) were measured by the pulsed-wave Doppler
method at the level of the mitral valve leaflet tips. Peak
early diastolic velocity (e’) and late diastolic velocity (a’)
were measured by tissue Doppler imaging from the septal
mitral annulus. The E/A and E/e’ ratios were calculated to
estimate the LV filling pressure [7]. Echocardiographic data
were analyzed by two cardiologists who were blinded to
the patients’ other information.
Echo-Doppler–derived parameters of ventricular stiffness
and ventriculo-arterial interaction
For the evaluation of the vulnerability of the LV, we mea-
sured ventricular stiffness and end-systolic ventriculo-
arterial interaction using echo-Doppler [8, 9]. Ventricular
diastolic elastance (Ed) was calculated as E/e’ divided by
stroke volume [11, 12]. Ventricular end-systolic elastance
(Ees) was required to describe the contractility of the LV
and was calculated based on pulsed-wave Doppler
echocardiography of trans-LV outflow tract (LVOT) as
peak velocity divided by acceleration time [13]. Peak
velocity of LVOT was measured at the point of max-
imal velocity and acceleration time was measured as
the time from the onset to the peak velocity. Effective
arterial elastance (Ea) provides an integrative measure
of arterial load and was defined as the ratio of end-
systolic pressure to stroke volume where end-systolic
pressure was calculated as (2 × systolic blood pressure
+ diastolic blood pressure)/3 [11, 12]. To evaluate the
interaction of the ventricular and arterial systems, the
ventricular–vascular coupling index (VVI) was calcu-
lated as the ratio Ea/Ees [14, 15].
Statistical analysis
Baseline characteristics were summarized for all partici-
pants using standard descriptive statistics. Continuous
variables are presented as mean ± standard deviation
and categorical variables as number and percentage.
Baseline characteristics of groups were compared using
independent t-tests for continuous variables and chi-
square tests for categorical variables. Variables without
normal distribution were presented as median (inter-
quartile range) and Mann-Whitney U test were used
for their comparisons.
Linear regression analyses were performed to determine
the association between echo-derived parameters and the
HF severity, estimated by EF and levels of log-transformed
brain natriuretic peptide (BNP). To achieve a constant
variance, BNP values were transformed logarithmically.
Cox proportional hazard models were used to determine
the association between Ed, Ees, Ea, and VVI, and the
development of new-onset AF. Adjustment variables were
selected based on the differences between two groups (AF
vs. sinus rhythm) and clinical rationale; they included age,
LA volume index(LAVI), and underlying disease. We also
used receiver operating characteristic curves to derive cut-
off values for predictors. Time-to-event data are reported
and displayed using the Gehan’s generalized Wilcoxon
method, with comparisons between groups performed
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using the log-rank testDifferences were considered statisti-
cally significant if the p-value was <0.05 when using two-
sided tests. All statistical analyses were performed using
SPSS 18.0 (SPSS Inc., Chicago, Illinois).
Results
Patient characteristics and echocardiographic parameters
are presented in Table 1. New-onset AF developed in 57
of the 349 patients studied (16.3 %). The mean age of
the study population was 62 ± 15 years and 238 (68 %)
were male. At the beginning of the study, all patients
were in normal sinus rhythm. The median follow-up
period was 30.3 months. Anticoagulation medication
was administered to all patients who developed AF and
had appropriate indications.
The new-onset AF group was older (67.7 ± 12.8 vs.
61.2 ± 15.7, p = 0.003) and had a higher prevalence of
hypertension (49.1 % vs. 32.2 %, p = 0.014) and diabetes
(33.3 % vs. 17.8 %, p = 0.008). The rate of ischemic car-
diomyopathy did not differ between the two groups. The
new-onset AF group used more diuretics (73.7 % vs.
44.9 %, p < 0.001) than the sinus rhythm group (Table 1).
This finding suggests that patients with AF may have
more symptoms of heart failure and more volume over-
loading conditions. The median BNP level was higher
(216.0 vs. 566.0, p = 0.011) in patients with AF.
There was no difference in LV end-diastolic diameter
(52.4 ± 7.1 vs. 52.4 ± 7.9 mm, p = 0.964), LV systolic func-
tion (EF: 36.9 ± 9.4 % vs. 35.3 ± 10.3 %, p = 0.249), LV mass
index (73.8 ± 27.6 vs. 74.8 ± 18.9 g/m2, p = 0.738), A
(0.72 ± 0.22 vs. 0.71 ± 0.25 m/s, p = 0.706), or e’ (0.71 ±
0.25 vs. 0.04 ± 0.02 m/s, p = 0.278). However, the new-
onset AF group had a larger LA volume index (36.1 ± 14.8
vs. 28.4 ± 12.7 mL/m2, p < 0.001), a higher E (0.79 ± 0.30
vs. 0.65 ± 0.23 m/s, p < 0.001), and a higher E/e’ ratio
(19.1 ± 7.2 vs. 15.2 ± 6.8, p < 0.001). A’ was significantly
lower in the new-onset AF group (0.07 ± 0.03 vs. 0.08 ±
0.02 m/s, p < 0.001) (Table 1). Among the echo-derived
Doppler indexes, Ed was significantly higher (0.47 ± 0.27
vs. 0.36 ± 0.22 /mL, p = 0.009) in the new-onset AF group.
Ees, Ea, and VVI did not differ significantly between the
two groups.
In linear regression, EF measured by echocardiography
was significantly correlated with Ed (β: -0.496, p < 0.001)
and Ea (β: -0.314, p < 0.001). In addition, BNP level was
significantly correlated with Ed (β: 0.609, p < 0.001), Ees
(β: 0.218, p =0.020) and Ea (β: 0.212, p =0.031) (Table 2).
These findings suggest that there are significant relation-
ships between HF severity, estimated by EF and BNP
level, and echo-derived Doppler parameters that reflect
ventricular stiffness (Ed) and arterial load (Ea).
Over a median follow up of 30.3 months, new-onset AF
developed in 57 patients (16.3 %). Lower EF was signifi-
cantly associated with new-onset AF (hazard ratio [HR]
0.97, p = 0.025). After adjustment for age, hypertension,
diabetes mellitus, use of diuretics and LAVI, EF was not
correlated with AF (HR 0.98, p = 0.250). Ed was also signifi-
cantly associated with new-onset AF, with a greater than
10-fold risk in an unadjusted model (HR 10.40, p < 0.001).
This association remained significant after adjustment for
age, hypertension, diabetes mellitus, use of diuretics and
LAVI, (HR 5.49, p = 0.018). Ea and VVI were associated
with new-onset AF after adjustment for age, hypertension,
diabetes mellitus, use of diuretics and LAVI (HR 1.66 and
1.06, p = 0.026 and 0.001, respectively) (Table 3). For sub-
group analysis, we devided our study population into two
groups: (1) heart failure with reduced EF (HFrEF, EF <
40 %) and (2) heart failure with preserved EF (HFpEF, EF ≥
40 %). In patients with HFrEF, Ea and VVI were associated
with new-onset AF after adjustment for age, hypertension,
diabetes mellitus, use of diuretics and LAVI (HR 1.73 and
1.04, p = 0.045 and 0.035, respectively) (Additional file 1).
Whereas, there was no independent parameter of LV stiff-
ness that associated with new-onset AF in patients with
HFpEF.
Further evaluation was performed to determine the
power of Ed in predicting AF occurrence. The optimal
cutoff value to predict AF was an Ed value of 0.33, with
corresponding sensitivity and specificity values of 71
and 58 %, respectively (receiver operating characteristic
curve: area under curve [AUC] = 0.646, p < 0.001) (Fig. 1).
Figure 2 shows the cumulative survival curves for AF
occurrence. The cumulative survival rate free of AF
occurrence was significantly higher in patients with
higher Ed (≥0.33) than in patients with lower Ed (<0.33)
(p < 0.001).
Discussion
The principle findings of this study are as follows: (1)
Ventricular stiffness and ventriculo-arterial interaction
could be measured by echo Doppler, and (2) Ed, Ea and
VVI were closely correlated with new-onset AF in pa-
tients with HF.
The variable effect of AF on patients with HF
AF is the most common arrhythmia [4, 9] and further ag-
gravates symptoms in patients with HF [9, 16]. AF occurs
in 10–20 % of mild to moderate cases of HF and in up to
50 % of patients with more advanced HF. The prevalence
of AF generally depends on the severity of the underlying
HF [17, 18]. In this study, only ambulatory patients with
stable HF were enrolled and new-onset AF developed in
16.3 % of patients.
The new-onset AF group was receiving diuretics at a
statistically significantly higher rate (73.7 % vs. 44.9 %,
p < 0.001). This finding suggests that these patients
were clinically identified as having volume overload or
elevated LV filling pressure and were being treated as
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Table 1 Intergroup comparison of clinical characteristics and echocardiographic parameters
Characteristic Sinus rhythm New-onset AF p-value
(n = 292) (n = 57)
Age (years) 61.2 ± 15.7 67.7 ± 12.8 *0.003
Male, n (%) 203 (69.5) 35 (61.4) 0.229
Body surface area (m2) 1.71 ± 0.23 1.68 ± 0.19 0.320
SBP (mmHg) 122.4 ± 23.3 115.4 ± 25.2 0.094
DBP (mmHg) 74.1 ± 16.0 68.1 ± 14.7 *0.032
Hypertension, n (%) 94 (32.2) 28 (49.1) *0.014
Diabetes mellitus, n (%) 52 (17.8) 19 (33.3) *0.008
Current smoker, n (%) 57 (19.5) 12 (21.1) 0.791
Ischemic CMP, n (%) 164 (56.2) 32 (56.1) 0.997
Chronic kidney disease, n (%) 29 (12.0) 10 (18.5) 0.264
BUN (mg/dL) 21.7 ± 14.9 24.4 ± 21.5 0.259
Creatinine (mg/dL) 1.4 ± 1.5 2.0 ± 2.3 0.095
BNP (pg/ml) Median: 216.0 (81.8–749) Median: 566.0(180.5-1302.5) *0.011
Medications
Antiplatelet agent, n (%) 218 (74.7) 46 (80.7) 0.400
RAS blockade, n (%) 243 (83.2) 49 (86.0) 0.608
Diuretics, n (%) 131 (44.9) 42 (73.7) * < 0.001
Beta blockade, n (%) 191 (65.4) 31 (54.4) 0.114
Calcium channel blockade, n (%) 88 (30.1) 21 (36.8) 0.318
Statin, n (%) 152 (52.1) 26 (45.6) 0.374
Echocardiographic parameters
Ejection fraction (%) 36.9 ± 9.4 35.3 ± 10.3 0.249
LVEDD (mm) 52.4 ± 7.1 52.4 ± 7.9 0.964
LVESD (mm) 42.0 ± 8.1 42.3 ± 8.7 0.814
LA-AP (mm) 37.8 ± 7.4 40.3 ± 7.5 *0.023
LA-ML (mm) 43.9 ± 7.5 47.8 ± 8.7 *0.001
LA-SI (mm) 52.8 ± 8.7 57.5 ± 9.7 * < 0.001
LA volume index (mm3/m2) 28.4 ± 12.7 36.1 ± 14.8 * < 0.001
LV mass index (g/m2) 73.8 ± 27.6 74.8 ± 18.9 0.738
E velocity (m/s) 0.65 ± 0.23 0.79 ± 0.30 * < 0.001
A velocity (m/s) 0.72 ± 0.22 0.71 ± 0.25 0.706
E/A 1.02 ± 0.63 1.22 ± 0.75 *0.036
E/DT (cm/s) 0.39 ± 0.27 0.55 ± 0.37 *0.003
e’ (m/s) 0.05 ± 0.02 0.04 ± 0.02 0.278
a’ (m/s) 0.08 ± 0.02 0.07 ± 0.03 *0.001
S’ (m/s) 0.05 ± 0.02 0.05 ± 0.02 0.223
E/e’ 15.2 ± 6.8 19.1 ± 7.2 * < 0.001
Ed (1/ml) 0.36 ± 0.22 0.47 ± 0.27 *0.009
Ees (m/s) 1.02 ± 0.24 1.11 ± 0.37 0.195
Ea (mmHg/ml) 2.67 ± 0.96 2.75 ± 1.43 0.717
VVI 25.5 ± 9.1 32.1 ± 16.8 0.115
Abbreviations: AF atrial fibrillation, CMP cardiomyopathy, BUN blood urea nitrogen, RAS renin-angiotensin system, LVEDD left ventricular end-diastolic dimension;
LVESD, left ventricular end-systolic dimension; LA left atrial; AP anteroposterior; ML mediolateral; SI Superoinferior; DT Deceleration time; Ed left ventricular (LV)
end-diastolic elastance; Ees, LV end-systolic elastance; Ea, effective arterial elastance; VVI, ventricular-vascular coupling index
* p < 0.05
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such. Recently, Cambell et al. showed that renal impair-
ment was strong predictor of AF in patients with HF
and should be regularly screened. In our study, preva-
lence of chronic kidney disease was not different be-
tween AF group and sinus rhythm group.
While LV systolic function was similar between the
two groups, patients with new-onset AF had significantly
higher LAVI, E/e’, and Ed. These findings suggest that
atrial dilation and reduced LV relaxation are related to
the development of AF and could be explained by dia-
stolic dysfunction.
The correlation between AF and diastolic dysfunction
Diastolic dysfunction, like systolic dysfunction, is known
to be associated with the development of AF [11, 13].
The presence of diastolic dysfunction is also a strong
predictor of AF occurrence and is closely associated with
a poor prognosis in patients with HF [19]. Diastolic dys-
function leads to elevated LV filling pressures and atrial
remodeling. The relationship between atrial remodeling
and AF has been investigated in many studies. Diastolic
dysfunction with an increase in LV filling pressures
causes atrial remodeling and is associated with a more
than 5-fold increased risk of AF occurrence compared
with normal diastolic function [20].
The assessment of diastolic dysfunction by
echocardiography
LV diastolic filling pressure can be measured by Doppler
echocardiography. Mitral inflow velocity (E) correlates
well with LV filling pressure in heart failure; however,
myocardial relaxation and filling pressure could affect the
mitral E velocity. The mitral e’ velocity reflects relaxation
of the myocardium and the E/e’ ratio correlates well with
LV filling pressure or pulmonary capillary wedge pressure
[21–23]. In this study, the AF group had significantly
higher E/e’ values compared with patients in normal sinus
rhythm.
In HF patients, increased ventricular stiffness
induces diastolic dysfunction, thereby causing an
elevation of LV filling pressure and increasing vul-
nerability to an acute loading change [14]. E/e’ is
significantly correlated with LV filling pressure [22],
while stroke volume can be used as an indicator of
LV filling volume. Thus, combining these parameters,
dividing E/e’ by stroke volume, represents the ratio
of LV filling pressure to filling volume and can be
used as the Ed [11]. We used Ed for the evaluation
of ventricular stiffness in this study. We found that
Ed was significantly correlated with EF and BNP,
which represent HF severity. Furthermore, a higher
Ed was independently associated with AF, after ad-
justment for age, hypertension, diabetes mellitus, use
of diuretics and LAVI. In addition, using receiver
operating characteristic analysis, we were able to de-
termine a cutoff value for LV filling pressure/volume,
as represented by the Ed value. According to our results,
the optimal cutoff value of Ed for the prediction of new-
onset AF was 0.33, with a sensitivity of 71 % and a specifi-
city of 58 %.
Ventriculo-arterial interaction
Increased afterload is also important in the pathophysi-
ology of HF [24]. The Ea was used as the total arterial
afterload and can be measured noninvasively [11, 12]. In
addition, the Ees is related to LV contractility, inde-
pendently of loading conditions [25]. The combination
of these parameters, called VVI, is the ratio Ea/Ees and
is used as an index of ventriculo-arterial coupling, as
previously described [14]. In our study, we found that
Ea was closely related to HF severity. Interestingly, our
study showed that Ea and VVI, as well as Ed, were
predictors of new-onset AF in patients with HF,
whereas Ees was not. These results suggest that ven-
tricular stiffness and ventriculo-arterial coupling are
important predictors of AF occurrence in HF patients.
In addition, ventricular stiffness and ventriculo-arterial
coupling are more relevant than LV contractility alone.
Table 2 Association of HF severity with ventricular stiffness and
ventriculoarterial interaction index by univariate linear
regression
Ejection fraction BNP(Log-transformed)
ß p-value ß p-value
Ed (1/ml) −0.496 * < 0.001 0.609 * <0.001
Ees (m/s) 0.001 0.991 0.218 * 0.020
Ea (mmHg/ml) −0.314 * < 0.001 0.212 * 0.031
VVI −0.190 0.064 0.040 0.735
Ed left ventricular (LV) diastolic elastance; Ees LV end-systolic elastance; Ea
effective arterial elastance; VVI ventricular-vascular coupling index
Table 3 Association between echocardiographic parameters
and new-onset atrial fibrillation
Unadjusted Adjusted
Hazard ratio p-value Hazard ratio p-value
Ejection fraction (%) 0.97 *0.025 0.98 0.250
Ed (1/ml) 10.40 * < 0.001 5.49 *0.018
Ea (mmHg/ml) 1.70 0.011 1.66 *0.027
Ees (m/s) 1.58 0.497 0.95 0.940
VVI 1.04 0.004 1.06 *0.001
Adjusted for age, hypertension, DM, use of diuretics and left atrial
volume index
Ed left ventricular (LV) diastolic elastance; Ea effective arterial elastance; Ees LV
end-systolic elastance; VVI ventricular-vascular coupling index
*p < 0.05
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Limitations
The present study had some limitations. First, since it was
a single-center study with a retrospective design, only lim-
ited data analysis was possible and follow-up durations
were arbitrary. Second, the occurrence of new-onset AF
might have been underestimated. Capturing AF is notori-
ously difficult, unless careful transtelephonic monitoring
or regular Holter recordings can be performed. We know
that relying on symptomatic presentation will underesti-
mate the occurrence of AF, given that much of AF is
asymptomatic. There is no way of knowing whether
patients in the “sinus rhythm” group actually had paroxys-
mal AF or not. Finally, the male predominance in the
study patients was a potential limitation, in that it did not
reflect the general clinical HF population; however, this is
a common failing shared with many other contemporary
HF studies.
Conclusions
Echo-Doppler–derived indexes of ventricular stiffness and
ventriculo-arterial coupling are associated with HF sever-
ity and are important predictors of new-onset AF in pa-
tients with HF. Therefore, HF patients with increased
ventricular stiffness may need close observation for the
development of AF, using techniques such as frequent
Holter monitoring.
Additional file
Additional file 1: Association between echocardiographic
parameters and new-onset atrial fibrillation in patients with heart
failure with reduced ejection fraction. (DOCX 16 kb)
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